TCON
Tracon Pharmaceuticals, Inc.
Opaleye Management Inc. bought $950K of Tracon Pharmaceuticals, Inc.
10% owner
Bought$950,378
$1.74Price
545,504Shares
+47%Stake
What TCON did for a copier
Prices for TCON after this filing aren't in yet.
Opaleye Management Inc.'s record
63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Aug 27. Filed Mon, Aug 31, 9:36 PM ET, after the close. Not investment advice.